Eye Know O.D. logo
Register
Email Address: *
First Name: *
Last Name: *
Title:
Profession:
Password: *
Confirm Password: *

By clicking “Register” you are agreeing to the Terms and Conditions and Privacy Policy.

Eysuvis®

Loteprednol etabonate 0.25%
ophthalmic suspension
Dry Eye/OSD
[ Corticosteroid]
Indication

Indication

short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.
Mechanism of Action

Mechanism of Action

Exerts anti-inflammatory effects by inhibiting phospholipase A2, leading to decreased formation of arachidonic acid derivatives like prostaglandins and leukotrienes. This action reduces inflammation and helps alleviate the symptoms of dry eye disease.
Common quantities available

Available Quantities

8.3 ml
Dosage

Dosage/Instructions

Shake for 2 to 3 seconds. Use 1 or 2 drops four times daily, up to 2 weeks if needed
Pregnancy & Nursing Data

Pregnancy & Nursing

Fetal malformations noted in rabbits with oral administration of 1.4 times the human ophthalmic dose. Use cautiously during pregnancy
Pediatric Use

Pediatric Use

No studies
Warnings Tab

Contraindications, side effects, etc.

Contraindications: Hypersensitivity to loteprednol etabonate or any components of the product. Warnings/Precautions: Use with caution in patients with glaucoma, cataracts, corneal or scleral thinning, bacterial/viral/fungal ocular infections. Prolonged use may increase intraocular pressure and risk of cataract formation. Common Side Effects: Minor burning or stinging upon instillation, blurred vision, dry eyes, and headache.